Escherichia coli in Chickens: Etiology, Clinical Signs, Pathology, Diagnostics, and Vaccine Strategies

Introduction

Avian colibacillosis, caused by avian pathogenic Escherichia coli (APEC), represents one of the most significant infectious disease syndromes affecting poultry production worldwide [1, 35]. Escherichia coli is a Gram-negative, facultative anaerobic bacillus belonging to the family Enterobacteriaceae. While many strains are commensal inhabitants of the avian intestinal tract, specific pathotypes have acquired virulence factors that enable them to cause extraintestinal disease [2, 32]. The economic impact of colibacillosis is substantial, manifesting as increased mortality, reduced growth performance, carcass condemnation, and costs associated with treatment and control [3, 4]. The emergence and dissemination of multidrug-resistant (MDR) strains, including those producing extended-spectrum beta-lactamases (ESBLs) and carbapenemases, have further complicated disease management and raised significant public health concerns regarding zoonotic transmission [5, 6, 7, 8].

Etiology and Pathotypes

Avian pathogenic E. coli strains belong to the extraintestinal pathogenic E. coli (ExPEC) group [1, 29]. They are distinguished from commensal strains by the presence of specific virulence-associated genes (VAGs) that facilitate colonization, immune evasion, and tissue damage [32, 35]. Key VAGs include those encoding adhesins (e.g., fimH, papC), iron acquisition systems (e.g., iroN, iucD, sitA), protectins (e.g., iss, ompT), and toxins (e.g., hlyF, vat) [1, 28, 35]. The presence of five or more of these genes is a commonly used criterion to define an isolate as APEC [32, 35].

Serogroups O1, O2, and O78 have historically been most frequently associated with colibacillosis outbreaks, although a wide antigenic diversity exists and emergent serotypes are continually reported [1, 26, 29]. Phylogenetic analysis places most APEC strains in phylogroups B2 and F, with phylogroup F being a strong predictor of colibacillosis in chickens [32]. Commensal isolates are more frequently assigned to phylogroups A and B1 [32].

Epidemiology and Transmission

The epidemiology of E. coli in chickens is complex, involving both vertical and horizontal transmission routes. The primary source of infection is the contaminated environment, as E. coli can persist in litter, dust, feed, and water [9, 10]. Fecal shedding from colonized birds is a major mechanism of spread, and the term chicken e coli poop refers to the direct excretion of bacteria into the environment, contaminating housing and facilitating rapid transmission within a flock [8, 10]. Studies have demonstrated that a very low oral dose, as few as 10^1 colony-forming units (CFU), can lead to persistent colonization in broiler chicks, and a seeder-bird model shows rapid transmission to sentinel birds even without antimicrobial selection pressure [10].

Risk factors for colibacillosis include poor biosecurity, high stocking density, poor ventilation, and concurrent infections with immunosuppressive or respiratory pathogens such as Mycoplasma gallisepticum or infectious bronchitis virus [11, 12]. Coinfection with Eimeria tenella can exacerbate the severity of colibacillosis [12]. Heat stress has been shown to aggravate intestinal inflammation and increase susceptibility to E. coli O157:H7 infection in chickens through upregulation of the TLR4-NF-κB signaling pathway [30]. The winter season and the use of antibiotics without veterinary prescription have been identified as significant risk factors for MDR E. coli infection in broiler flocks [8].

Clinical Signs

The clinical presentation of colibacillosis varies depending on the age of the bird, the route of infection, and the virulence of the strain. In neonatal chicks, infection often presents as yolk sac infection (omphalitis), characterized by lethargy, anorexia, and increased mortality [27]. In older birds, the respiratory form is common, often secondary to a primary respiratory viral or mycoplasma infection [11]. Clinical signs include dyspnea, rales, coughing, and nasal discharge [26].

The septicemic form is acute and can cause sudden death without premonitory signs. Affected birds may exhibit depression, ruffled feathers, closed eyes, and reluctance to move [26]. Diarrhea is a frequent sign, and the appearance of chicken e coli poop can range from watery to mucoid or blood-tinged feces [31]. Localized infections, such as cellulitis (inflammation of the subcutaneous tissue) and synovitis (inflammation of the joints), can also occur, leading to lameness and swollen joints [1]. Experimental infections with serotypes O78 and O26 have been shown to produce more severe clinical signs and higher mortality compared to other serotypes [26].

Pathology

Gross pathological lesions are highly characteristic of colibacillosis. The hallmark lesions include fibrinous polyserositis, which manifests as pericarditis (thickening and opacity of the pericardial sac with fibrinous exudate), perihepatitis (a fibrinous coat covering the liver), and airsacculitis (thickened, cloudy air sacs with fibrinous deposits) [13, 26]. These lesions are often described as "airsacculitis-pericarditis-perihepatitis" complex [13]. In acute septicemia, the liver and spleen may be enlarged and congested, with petechial hemorrhages on the heart and serosal surfaces [26]. Enteritis, characterized by congestion and thickening of the intestinal wall, is also commonly observed [26].

Histopathological examination reveals severe fibrinoheterophilic inflammation in affected serosal surfaces [26]. In the lungs, congestion, edema, and infiltration of heterophils are seen [14, 26]. In the ileum, E. coli lipopolysaccharide (LPS) can induce villus atrophy, disruption of the epithelial barrier, and apoptosis [15, 16]. The expression of innate immune molecules such as chicken surfactant protein A (cSP-A) and chicken lung lectin (cLL) is co-upregulated in the lung and trachea following APEC infection, indicating a role in early host defense [14].

Diagnostics

A definitive diagnosis of colibacillosis requires the isolation and identification of E. coli from affected tissues (e.g., liver, spleen, heart blood, bone marrow) of diseased birds, preferably from lesions characteristic of the disease [1, 26]. Samples are plated on selective media such as MacConkey agar, where E. coli appears as pink, lactose-fermenting colonies [17, 8]. Biochemical confirmation can be performed using standard tests (e.g., indole, methyl red, Voges-Proskauer, citrate) or commercial identification systems [8].

Molecular diagnostics are essential for pathotyping and antimicrobial resistance (AMR) profiling. Polymerase chain reaction (PCR) assays are used to detect specific VAGs to differentiate APEC from commensal strains [18, 1, 35]. Multiplex PCR can simultaneously screen for genes such as iroN, ompT, hlyF, iss, iucD, tsh, and vat [35]. Detection of AMR genes, including ESBL genes (blaCTX-M, blaSHV, blaTEM), carbapenemase genes (blaNDM), and the colistin resistance gene mcr-1, is critical for surveillance [6, 19, 28, 29, 33].

Whole-genome sequencing (WGS) has become a powerful tool for high-resolution typing, phylogenetic analysis, and comprehensive characterization of virulence and resistance determinants [6, 7, 28]. WGS can identify sequence types (STs), plasmid replicons, and the genetic context of mobile resistance elements, providing insights into the epidemiology and evolution of MDR strains [6, 28]. Serotyping, either by traditional antisera agglutination or molecular methods targeting O-antigen genes, remains useful for epidemiological tracking [1, 26].

Antimicrobial Resistance

Antimicrobial resistance in E. coli from chickens is a global crisis [5, 6, 7, 8]. High rates of resistance have been reported to tetracyclines, penicillins, sulfonamides, and fluoroquinolones [5, 8, 28, 33]. Multidrug resistance, defined as resistance to three or more classes of antimicrobials, is extremely common, with prevalence rates often exceeding 75% in many studies [5, 8, 28, 33]. The presence of ESBL-producing E. coli in market-ready chickens poses a direct threat to food safety and human health [6, 19]. Critically important resistance mechanisms, such as carbapenem resistance mediated by blaNDM and colistin resistance mediated by mcr-1, have been identified in chicken isolates, including those from healthy birds, highlighting the role of the food chain in the dissemination of these genes [6, 7, 29, 33]. The co-occurrence of mcr-1 and blaNDM in the same isolate is particularly alarming [29].

Treatment and Control

Antimicrobial Therapy

Treatment of colibacillosis has traditionally relied on antimicrobial therapy. However, the high prevalence of MDR strains has severely compromised the efficacy of many first-line drugs [5, 4]. Antimicrobial susceptibility testing is essential to guide therapy [20]. The use of antimicrobials in poultry production is increasingly regulated to mitigate the spread of AMR [8].

Alternative Therapeutic Strategies

Given the limitations of antibiotics, alternative strategies are being actively investigated. Antimicrobial peptides (AMPs), such as the chicken cathelicidin CATH-2-derived peptide C2-2, have shown potent in vitro and in vivo activity against MDR E. coli, improving survival and reducing bacterial load in experimentally infected chickens [3]. Bacteriophage therapy, using lytic phages like T4-like phage Bp7, represents another promising approach for controlling drug-resistant E. coli [21].

Probiotics and competitive exclusion (CE) cultures offer a non-antibiotic strategy to reduce intestinal colonization. Lacticaseibacillus rhamnosus GG has been shown to reduce E. coli adhesion to intestinal epithelial cells, improve growth performance, and enhance innate immunity in chickens [22]. Lactobacillus salivarius can ameliorate lung inflammation and secondary E. coli infection following Mycoplasma gallisepticum infection by modulating the gut microbiota [11]. Lactobacillus acidophilus supplementation improves growth performance, intestinal barrier function, and survival in broilers challenged with E. coli O157 [34]. A CE culture of undefined composition has been shown to substantially reduce cecal colonization by ESBL/AmpC-producing E. coli in young chicks [23].

Phytogenic feed additives are also being explored. Dihydromyricetin, a natural flavonoid, attenuates LPS-induced ileum injury in chickens by inhibiting the NLRP3 inflammasome and TLR4/NF-κB signaling pathway [15]. Isoquinoline alkaloids from Macleaya cordata alleviate LPS-induced intestinal epithelium injury by co-regulating TLR4/MyD88/NF-κB and Nrf2 signaling pathways [16]. Combinations of traditional Chinese medicine extracts (e.g., Taraxacum and Astragalus) with probiotics have shown synergistic protective effects against E. coli infection in broilers [31].

Vaccine Strategies

Vaccination is a cornerstone of long-term colibacillosis control. The development of effective vaccines is challenging due to the high antigenic diversity of APEC strains [1]. Several vaccine platforms have been investigated.

Bacterin vaccines, composed of inactivated whole cells of common serotypes (e.g., O1, O2, O78), are commercially available but often provide limited cross-protection against heterologous strains [1].

Live attenuated vaccines and recombinant attenuated Salmonella vaccines (RASV) have shown promise. RASV can elicit cross-reactive immune responses against APEC, and when combined with probiotics, can enhance protection against APEC challenge and reduce fecal shedding of Salmonella [13].

Subunit vaccines targeting conserved virulence factors, such as the iron-regulated proteins IroN and IutA, are under development. Vaccination with these antigens can induce bactericidal antibodies against multiple APEC serotypes [13].

Outer membrane vesicle (OMV) vaccines represent a novel platform. OMVs derived from Salmonella Typhimurium mutants with a remodeled outer membrane (e.g., lacking major OMPs OmpA, OmpC, OmpD) have been shown to elicit significant cross-protection against both Salmonella Enteritidis and APEC O78 in chickens [24].

Selective breeding for enhanced natural disease resistance is a non-vaccine genetic strategy. Chickens divergently selected for high levels of natural antibodies (NAb) binding keyhole limpet hemocyanin (KLH) have demonstrated 50-60% reduced mortality following APEC challenge compared to low-NAb lines [25].

Control and Biosecurity

Effective control of colibacillosis relies on a comprehensive management approach. Strict biosecurity measures, including all-in/all-out production, cleaning and disinfection of houses, and control of rodents and other vectors, are essential to reduce environmental contamination [5, 8]. Optimizing housing conditions to minimize stress factors such as poor ventilation, high ammonia levels, and overcrowding is critical [30]. The use of autogenous vaccines, prepared from the specific APEC strains circulating on a farm, can be a valuable tool for targeted control [1].

flowchart TD
    A[Colibacillosis Suspect], > B{Clinical Signs & History}
    B, > C[Post-Mortem Examination]
    C, > D[Gross Lesions: Pericarditis, Perihepatitis, Airsacculitis]
    D, > E[Sample Collection: Liver, Spleen, Heart Blood, Bone Marrow]
    E, > F[Bacteriological Culture on MacConkey Agar]
    F, > G[Lactose-Fermenting Colonies]
    G, > H[Biochemical Identification]
    H, > I[Confirmed E. coli]
    I, > J{Diagnostic Objectives}
    J, > K[Pathotyping]
    J, > L[AMR Profiling]
    J, > M[Epidemiological Typing]
    K, > N[PCR for VAGs: iroN, ompT, hlyF, iss, etc.]
    L, > O[Phenotypic AST (Disk Diffusion/Broth Microdilution)]
    L, > P[Genotypic AMR Detection: PCR/WGS for blaCTX-M, mcr-1, blaNDM]
    M, > Q[Serotyping (O-antigen)]
    M, > R[MLST/WGS for ST and Phylogeny]
    N, > S[APEC Confirmation]
    O & P, > T[MDR Profile]
    Q & R, > U[Epidemiological Link]
    S & T & U, > V[Informed Control Strategy: Vaccination, Biosecurity, Targeted Therapy]

Conclusion

Escherichia coli remains a major pathogen in chicken production, causing significant economic losses and posing a zoonotic threat through the food chain. The high prevalence of MDR strains, including those resistant to critically important antibiotics, necessitates a paradigm shift from reliance on antimicrobial therapy to integrated control strategies. These strategies must combine robust biosecurity, optimized management, alternative therapeutics (probiotics, AMPs, phages), and effective vaccination programs. Advanced molecular diagnostics, including WGS, are essential for surveillance and guiding intervention measures. A One Health approach, recognizing the interconnectedness of human, animal, and environmental health, is paramount to combat the spread of MDR E. coli [5, 6, 7].

References

[1] Ali, A., El-Mawgoud, A. I. A., Dahshan, A. M., et al. (2019). Escherichia coli in broiler chickens in Egypt, its virulence traits and vaccination as an intervention strategy. Novel Research in Microbiology Journal. https://www.semanticscholar.org/paper/0c6521923c545f858a53b11bf506c2111b05016f

[2] Kariuki, S., Gilks, C., Kimari, J., et al. (2002). Carriage of Potentially Pathogenic Escherichia coli in Chickens. Avian Diseases. https://www.semanticscholar.org/paper/9931193d99b6636149d7d7caba37259d849d3dad

[3] Hao, S., Shi, W., Chen, L., et al. (2024). CATH-2-derived antimicrobial peptide inhibits multidrug-resistant Escherichia coli infection in chickens. Frontiers in Cellular and Infection Microbiology. https://www.semanticscholar.org/paper/a8fe201c3172b04c5426911e5a33f90b2251f741

[4] Gao, J., Duan, X., Li, X., et al. (2018). Emerging of a highly pathogenic and multi-drug resistant strain of Escherichia coli causing an outbreak of colibacillosis in chickens

[5] Sonola, V. S., Katakweba, A. S., Misinzo, G., et al. (2021). Occurrence of Multi-Drug-Resistant Escherichia coli in Chickens, Humans, Rodents and Household Soil in Karatu, Northern Tanzania. Antibiotics. https://www.semanticscholar.org/paper/4fb54eabd268b165ccf9a4ef5e968bf4df308b1e

[6] Ma, J., Bai, S., Xu, J. Q., et al. (2025). Molecular epidemiology of New Delhi metallo-β-lactamase-producing Escherichia coli in retail market chickens, Shandong, China. Frontiers in Microbiology. https://www.semanticscholar.org/paper/e20f8c65b9308cb3f5671e47689cfe1434ea9752

[7] Murray, M., Salvatierra, G., Dávila-Barclay, A., et al. (2021). Market Chickens as a Source of Antibiotic-Resistant Escherichia coli in a Peri-Urban Community in Lima, Peru. Frontiers in Microbiology. https://www.semanticscholar.org/paper/2d1ba5a47afc49f63afef82a7b81b58eed21121d

[8] Mandal, A., Talukder, S., Hasan, M., et al. (2021). Epidemiology and antimicrobial resistance of Escherichia coli in broiler chickens, farmworkers, and farm sewage in Bangladesh. Veterinary Medicine and Science. https://www.semanticscholar.org/paper/5d0657b742a3da966c85faff0eb4f9f99b645e5c

[9] Saleha, A., Myaing, T. T., Ganapathy, K., et al. (2009). Possible Effect of Antibiotic-Supplemented Feed and Environment on the Occurrence of Multiple Antibiotic Resistant Escherichia coli in Chickens. Journal. https://www.semanticscholar.org/paper/b4e427b5ba66140e02a5c862d00b44043a3c241c

[10] Robé, C., Blasse, A., Merle, R., et al. (2019). Low Dose Colonization of Broiler Chickens With ESBL-/AmpC- Producing Escherichia coli in a Seeder-Bird Model Independent of Antimicrobial Selection Pressure. Frontiers in Microbiology. https://www.semanticscholar.org/paper/55233ce66bf42cc3ddd5ecee8fd5fd09edcf1c57

[11] Wang, J., Ishfaq, M., & Li, J. (2021). Lactobacillus salivarius ameliorated Mycoplasma gallisepticum-induced inflammatory injury and secondary Escherichia coli infection in chickens: Involvement of intestinal microbiota. Veterinary Immunology and Immunopathology. https://www.semanticscholar.org/paper/fba801703d7d32b7501bf402ed3eb22a2f63a056

[12] Nakamura, K., Isobe, T., & Narita, M. (1990). Dual infections of Eimeria tenella and Escherichia coli in chickens. Research in Veterinary Science. https://www.semanticscholar.org/paper/2611cc5583df960ebf0270d9f33100b616b72e96

[13] Redweik, G. A. J., Stromberg, Z., Van Goor, A., et al. (2019). Protection against avian pathogenic Escherichia coli and Salmonella Kentucky exhibited in chickens given both probiotics and live Salmonella vaccine. Poultry Science. https://www.semanticscholar.org/paper/fc1d9de33313860514ef73b6355a17d3e155c083

[14] Wu, H., Xiong, H., Huang, X., et al. (2022). Lung infection of avian pathogenic Escherichia coli co-upregulates the expression of cSP-A and cLL in chickens. Research in Veterinary Science. https://www.semanticscholar.org/paper/0c6fae60ec3ceb6e0c93992c90b6a141fb6c61e9

[15] Chang, Y., Yuan, L., Liu, J., et al. (2020). Dihydromyricetin attenuates Escherichia coli lipopolysaccharide-induced ileum injury in chickens by inhibiting NLRP3 inflammasome and TLR4/NF-κB signalling pathway. Veterinary Research. https://www.semanticscholar.org/paper/2eb3d81c2eaf25e2725be47b1b35a6b5e81d3269

[16] Liu, Y., Han, K., Liu, H. Y., et al. (2024). Macleaya cordata isoquinoline alkaloids attenuate Escherichia coli lipopolysaccharide-induced intestinal epithelium injury in broiler chickens by co-regulating the TLR4/MyD88/NF-κB and Nrf2 signaling pathways. Frontiers in Immunology. https://www.semanticscholar.org/paper/f4a8e94b8e8b467ad747053388b0bcf5ae64130e

[17] Trung, N. V., Nhung, H. N., Carrique-Mas, J., et al. (2016). Colonization of Enteroaggregative Escherichia coli and Shiga toxin-producing Escherichia coli in chickens and humans in southern Vietnam. BMC Microbiology. https://www.semanticscholar.org/paper/c35f5311937fa937ae5db3eddf1eeca769e3db0a

[18] Al-Gallas, N., Fadel, M., Altammar, K. A., et al. (2024). Pathovars, occurrence and characterization of plasmid-mediated quinolone resistance in diarrhoeal Escherichia coli isolated from farmers and farmed chickens in Tunisia and Nigeria. Letters in Applied Microbiology. https://www.semanticscholar.org/paper/7f91081245ed5c56687f2bbc0bb804f5ccb97ca2

[19] Chishimba, K., Hang’ombe, B., Muzandu, K., et al. (2016). Detection of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Market-Ready Chickens in Zambia. International Journal of Microbiology. https://www.semanticscholar.org/paper/692f7ced10a0d43e75cfe5e1a428348a22d2f8f6

[20] Prasad, V., Murthy, K. K., & Rao, T. (1997). IN VITRO ANTIBIOGRAM STUDIES OF ESCHERICHIA COLI IN CHICKENS. Journal. https://www.semanticscholar.org/paper/36b7554cc270505a139028f84e100b60b3972939

[21] Zhang, C., Li, W., Liu, W., et al. (2013). T4-Like Phage Bp7, a Potential Antimicrobial Agent for Controlling Drug-Resistant Escherichia coli in Chickens. Applied and Environmental Microbiology. https://www.semanticscholar.org/paper/75644d4527ba96b8ae9adef9e69bc37e132b9ed9

[22] Guo, M., Zhang, C., Zhang, C., et al. (2021). Lacticaseibacillus rhamnosus Reduces the Pathogenicity of Escherichia coli in Chickens. Frontiers in Microbiology. https://www.semanticscholar.org/paper/11156bc31b681f9f8cacc5ab3a84096c781668d7

[23] Methner, U., Friese, A., & Rösler, U. (2019). Competitive exclusion: A tool to combat extended-spectrum β-lactamase-producing Escherichia coli strains in chickens. Research in Veterinary Science. https://www.semanticscholar.org/paper/4d31c9b2bb8630fc0d67c3722b35af13933aff7f

[24] Chen, Y., Jie, K., Li, B., et al. (2020). Immunization With Outer Membrane Vesicles Derived From Major Outer Membrane Protein-Deficient Salmonella Typhimurium Mutants for Cross Protection Against Salmonella Enteritidis and Avian Pathogenic Escherichia coli O78 Infection in Chickens. Frontiers in Microbiology. https://www.semanticscholar.org/paper/1e6c06c05162eb2568b3e348c579d565ccf1a5f4

[25] Berghof, T., Matthijs, M., Arts, J., et al. (2019). Selective breeding for high natural antibody level increases resistance to avian pathogenic Escherichia coli (APEC) in chickens. Developmental and Comparative Immunology. https://www.semanticscholar.org/paper/b5d639573d6e56da85b0c3395f880f65b0c9e519